Abstract
Type I Interferon (IFN-α/β) is an innate cytokine important for fighting infections and is used to treat a variety of diseases. Here, we show that IFN-α/β plays a role in shaping the Th2 response in humans. We propose that activation of this Th2 regulatory pathway with IFN-α/β, or other antagonist with fewer side effects, will be helpful in the treatment of severe asthma and other chronic atopic diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
